Fig 1.
Consort flowchart.
Fig 2.
Fasting glucose values at baseline (T1) and after four days of dexamethasone treatment (T2). N = 42.
Table 1.
Laboratory measurements.
Fig 3.
Insulin values at baseline and after four days of dexamethasone treatment. N = 40.
Fig 4.
HOMA-IR values at baseline and after four days of dexamethasone treatment. N = 39.
Fig 5.
Dexamethasone-induced change in HDL, LDL, total cholesterol, triglycerides, and glucose (mmol/L) from T1 to T2. * = P<0.05 and ** = P<0.01 (Student’s paired t-test). The horizontal lines indicate the median change.
Fig 6.
Dexamethasone-induced changes in diastolic and systolic blood pressure (BP) SDS values after four days of dexamethasone treatment. N = 43. * = P<0.05 and ** = P<0.01 (Wilcoxon signed-rank test). The horizontal lines indicate the median change.
Table 2.
Components of the metabolic syndrome.
Fig 7.
Dexamethasone levels and glucose.
Glucose levels measured at T2 plotted against dexamethasone trough serum levels for each patient (N = 24). The two values were significantly correlated (Spearman’s coefficient (r): 0.63, P<0.01).